Commonwealth Equity Services, LLC Isoray, Inc. Transaction History

Commonwealth Equity Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	N/A	6,000 Added 14.19%	48,284 $57,000
Q2 2023 Aug 10, 2023	SELL	$0.0 - $0.69 $0 - $690	-1,000 Reduced 2.31%	42,284 $28,000
Q1 2023 May 11, 2023	BUY	$0.0 - $0.67 $0 - $11,390	17,000 Added 64.68%	43,284 $27,000
Q4 2022 Feb 07, 2023	SELL	$0.24 - $0.4 $240 - $400	-1,000 Reduced 3.67%	26,284 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.22 - $0.43 $220 - $430	1,000 Added 3.8%	27,284 $6,000
Q4 2021 Jan 31, 2022	SELL	$0.38 - $0.68 $5,130 - $9,180	-13,500 Reduced 33.93%	26,284 $10,000
Q1 2021 May 04, 2021	BUY	$0.53 - $2.47 $530 - $2,470	1,000 Added 2.58%	39,784 $43,000
Q2 2020 Aug 12, 2020	BUY	$0.47 - $0.86 $6,345 - $11,610	13,500 Added 53.39%	38,784 $21,000
Q3 2019 Oct 30, 2019	BUY	$0.31 - $0.42 $7,838 - $10,619	25,284 New	25,284 $8,000

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.